SRF Ltd Q1 FY26: Chemicals, Capex & Chaos—Is This a Science Experiment or a Stock?
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
1. At a Glance
SRF Ltd just pulled off a 71% PAT growth flex in Q1 FY26. Revenue? ₹3,819 Cr. Capex? ₹740 Cr approved in a single board meeting. Shareholders? Still wondering how a chemical company is out-earning their entire family tree. From BOPP films to specialty chemicals, SRF is playing a multi-inning game—with a lab coat on.
2. Introduction with Hook
Imagine a Swiss Army knife… but it smells like solvents, prints on plastic, and manufactures aluminum foils. That’s SRF. A company that’s doing so many things, your CA might faint trying to model it.
Key Stat #1: Net profit grew 71% YoY in Q1 FY26 to ₹432 Cr. Key Stat #2: Approved ₹740 Cr capex for two new plants while most companies can’t even approve tea budgets.
SRF doesn’t just make stuff—it compounds it. Literally and financially.
3. Business Model (WTF Do They Even Do?)
SRF does:
Specialty Chemicals: The “secret sauce” for your pesticides, pharma and new-age applications.
Packaging Films: Basically glorified gift wrap for industrial goods.